Erlotinib (OSI-774, Tarceva™), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer

Mary Hightower; Chandra P. Belani; Vinay K. Jain

doi:10.1016/S1525-7304(11)70302-3

Erlotinib (OSI-774, Tarceva™), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer

Mary Hightower
, Chandra P. Belani
, Vinay K. Jain

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	336-338
Number of pages	3
Journal	Clinical Lung Cancer
Volume	4
Issue number	6
DOIs	https://doi.org/10.1016/S1525-7304(11)70302-3
State	Published - May 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.1016/S1525-7304(11)70302-3

Cite this

@article{c5b6e05f850b494ebc36d21ad5a27a81,

title = "Erlotinib (OSI-774, Tarceva{\texttrademark}), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer",

author = "Mary Hightower and Belani, \{Chandra P.\} and Jain, \{Vinay K.\}",

year = "2003",

month = may,

doi = "10.1016/S1525-7304(11)70302-3",

language = "English (US)",

volume = "4",

pages = "336--338",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Erlotinib (OSI-774, Tarceva™), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer

AU - Hightower, Mary

AU - Belani, Chandra P.

AU - Jain, Vinay K.

PY - 2003/5

Y1 - 2003/5

UR - https://www.scopus.com/pages/publications/0038080166

UR - https://www.scopus.com/pages/publications/0038080166#tab=citedBy

U2 - 10.1016/S1525-7304(11)70302-3

DO - 10.1016/S1525-7304(11)70302-3

M3 - Article

C2 - 14599299

AN - SCOPUS:0038080166

SN - 1525-7304

VL - 4

SP - 336

EP - 338

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 6

ER -

Erlotinib (OSI-774, Tarceva™), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this